Why the study?
Does 18F-FAPI PET/CT imaging predict 5-year risk of sudden cardiac death in patients with hypertrophic cardiomyopathy?
Does 18F-FAPI PET/CT imaging predict 5-year risk of sudden cardiac death in patients with hypertrophic cardiomyopathy?
Answers are grounded in this paper and cite their sources.
18F-FAPI PET/CT imaging shows intense and heterogeneous activity in hypertrophic cardiomyopathy, which is significantly associated with the 5-year risk of sudden cardiac death.
= .03). Conclusion Fibroblast activation protein inhibitor (FAPI) PET/CT imaging indicated intense and heterogeneous activity in hypertrophic cardiomyopathy, and FAPI uptake was associated with 5-year risk of sudden cardiac death.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: